Suchergebnisse - "Sarilumab"

PubPharm (60)

1

Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19 : a systematic review and meta-analysis

enthalten in: Emerging microbes & infections | 2022

von Yu, S. | Koh, D. | Choi, M. | +4

2

Correspondence on : 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al

enthalten in: Annals of the rheumatic diseases | 2022

von Cheng, C. | Zhang, F.

CommentOn: Ann Rheum Dis. 2020 Oct;79(10):1277-1285. - PMID 32620597

3

Impact of sarilumab on mechanical ventilation in patients with COVID-19. Response to : 'Correspondence on: 'Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation-an open-label cohort study' by Della-Torre et al' by Cheng and Zhang

enthalten in: Annals of the rheumatic diseases | 2022

von Della-Torre, E. | Landoni, G. | Zangrillo, A. | +1

CommentOn: Ann Rheum Dis. 2020 Oct;79(10):1277-1285. - PMID 32620597

4

Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019 : A Randomized Clinical Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Sivapalasingam, S. | Lederer, D. | Bhore, R. | +37

5

Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID-19 patients : A systematic review and meta-analysis

enthalten in: Reviews in medical virology | 2022

von Peng, J. | Fu, M. | Mei, H. | +5

6

Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation : the SARICOR Randomized Clinical Trial

enthalten in: Antimicrobial agents and chemotherapy | 2022

von Merchante, N. | Cárcel, S. | Garrido-Gracia, J. | +17

7

A guide to immunotherapy for COVID-19

enthalten in: Nature medicine | 2022

von van de Veerdonk, F. | Giamarellos-Bourboulis, E. | Pickkers, P. | +12

8

The Activin/FLRG Pathway Associates with Poor COVID-19 Outcomes in Hospitalized Patients

enthalten in: Molecular and cellular biology | 2022

von McAleavy, M. | Zhang, Q. | Ehmann, P. | +14

9

Subcutaneous sarilumab for the treatment of hospitalized patients with moderate to severe COVID19 disease : A pragmatic, embedded randomized clinical trial

enthalten in: PloS one | 2022

von Branch-Elliman, W. | Ferguson, R. | Doros, G. | +18

10

Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19 : A network meta-analysis

enthalten in: PloS one | 2022

von Godolphin, P. | Fisher, D. | Berry, L. | +10

1
2
3
4
5
6
Nächster »
[6]